ArticleBMC medical imaging2026
Construction of a small-sample brain imaging data augmentation and explainable diagnostic model for autism based on generative adversarial networks.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized primarily by social communication deficits and repetitive stereotyped behaviors. Its objective diagnosis has long relied on clinical scale assessments, lacking automated tools based on brain imaging.
methodThis study proposes an ASD auxiliary diagnostic framework integrating conditional generative adversarial network (conditional GAN, cGAN) data augmentation, multimodal feature fusion, and explainable deep learning, based on the ABIDE I/II multi-center public datasets. First, functional connectivity matrices of AAL-116 brain regions were extracted from resting-state functional magnetic resonance imaging (rs-fMRI), and cortical morphological features were derived from structural magnetic resonance imaging (sMRI). Multi-site scanning biases were corrected using the ComBat method. On this basis, minority class samples were augmented using class-conditional GAN, followed by multimodal information fusion via a dual-branch encoder and cross-attention mechanism, ultimately outputting classification decisions between ASD and typically developing (TD) subjects.
resultsExperimental results demonstrate that, under stratified five-fold cross-validation, the proposed method achieved an AUC of 0.871 ± 0.016 and a balanced accuracy of 0.797 ± 0.012 on the full multimodal sample set, representing improvements of 13.2% and 9.2% over single sMRI and rs-fMRI modalities, respectively. Leave-one-site-out (LOSO) cross-validation yielded an average AUC of 0.783 ± 0.041, validating the model's cross-center generalization capability.
conclusionExplainability analysis based on Integrated Gradients revealed that the default mode network and social brain regions are key decision bases for distinguishing ASD from TD, highly consistent with existing neurobiological evidence. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.